TMJ prolotherapy may be considered for selected jaw pain, clicking, locking, instability, or hypermobility-related TMJ symptoms.
TMJ dysfunction can have many underlying causes, including joint instability and hypermobility. Dr. Siefferman explains how prolotherapy may help strengthen supporting ligaments, improve joint stability, and reduce jaw pain.
Our team organizes conditions and treatments into related zones of expertise to make it easier to explore the care paths most relevant to your symptoms and goals.
Use the zone tags above to browse dedicated pages for each focus area, including services, providers, and what to expect during treatment.
Hi, I’m Dr. Jason Siefferman, medical director at Manhattan Pain Medicine. TMJ dysfunction is something that we see frequently and as part of our assessment for TMJ dysfunction, we want to understand what is the dysfunction, why is it happening, what’s going on. Sometimes the patient is hypermobile and if that patient is hypermobile, essentially the joint is loose. The capsule and the ligaments that support support the joint are too stretchy.
As a result, the joint is not stable. When the joint is not stable, it may click, pop, dislocate, and the muscles that stabilize the joint will become hyperactive to do the job that the ligaments are not doing. One of the treatments that we use for this situation is dextrose prolotherapy. Dextrose is sugar and the sugar when injected around these ligaments causes a chemical irritation that stimulates increased collagen production. The dextrose will make the ligaments stronger. It will also tighten the joint capsule. So for a patient who is hypermobile without an underlying autoimmune process, we will use regenerative medicine to tighten the joint so it restores function.
TMJ prolotherapy is a regenerative injection approach that may be considered for selected patients with temporomandibular joint pain, jaw instability, clicking, locking, hypermobility-related TMJ symptoms, or chronic mechanical irritation. It is not a universal TMJ treatment and should not be used without careful evaluation. TMJ pain can come from the joint, muscles, disc position, bite mechanics, dental disease, cervical spine dysfunction, headache disorders, nerve pain, inflammatory arthritis, or central pain mechanisms.
At Manhattan Pain Medicine, TMJ prolotherapy NYC care begins with diagnosis-first evaluation to determine whether joint laxity, ligamentous support, or instability appears clinically relevant.
MPM specialists evaluate TMJ prolotherapy by first clarifying what is driving the patient’s jaw pain or dysfunction. Jaw clicking, locking, slipping, clenching, facial pain, neck pain, headache overlap, and hypermobility-related symptoms can come from different sources.
MPM reviews jaw mechanics, cervical mechanics, hypermobility history, EDS-related symptoms, prior dental care, bite or splint use, muscle overactivity, headache patterns, neurologic symptoms, and imaging when relevant. This helps determine whether prolotherapy, PRP, Botox, dental care, physical therapy, or coordination with an orofacial pain specialist, dentist, oral surgeon, neurologist, or headache specialist may be more appropriate.
TMJ prolotherapy may be most relevant when symptoms appear related to joint laxity, ligamentous support, instability, or chronic mechanical irritation around the jaw joint. This may be considered in selected patients with hypermobility, EDS, recurrent jaw clicking, jaw slipping, jaw instability, or TMJ symptoms that overlap with neck pain and cervical instability concerns.
MPM does not present TMJ prolotherapy as a cure for TMJ dysfunction or as a guaranteed way to tighten ligaments, reposition the disc, rebuild cartilage, or avoid surgery. TMJ symptoms can be muscular, dental, neurologic, inflammatory, joint-related, cervical, or headache-related. Some patients may need conservative TMJ care first, including dental evaluation, splints, soft diet, jaw exercises, physical therapy, medication management, Botox for muscle overactivity, PRP, or specialist care. MPM focuses on careful patient selection, realistic expectations, informed consent, and coordination when needed.
TMJ prolotherapy fits most closely within MPM’s Hypermobility expertise. Patients with EDS, hypermobility spectrum disorder, joint instability, cervical instability concerns, jaw clicking, jaw slipping, or recurrent TMJ irritation may have symptoms that reflect more than local jaw pain. The jaw joint may be influenced by ligamentous support, cervical mechanics, muscle guarding, bite patterns, headache overlap, and nervous system sensitivity.
MPM evaluates these relationships before recommending treatment. TMJ prolotherapy is not a cure for EDS, hypermobility, CCI, Chiari malformation, intracranial hypertension, jugular stenosis, tethered cord, headache disorders, or chronic pain. For selected patients, it may be one part of a broader care plan that includes stabilization, jaw mechanics, dental care, orofacial pain evaluation, physical therapy, pain psychology, medication management, or other targeted interventions.
Before TMJ prolotherapy, MPM reviews the diagnosis, suspected pain generator, jaw mechanics, prior treatments, risks, alternatives, and recovery expectations. Patients may be asked about clicking, locking, jaw slipping, clenching, chewing pain, facial pain, neck pain, headaches, hypermobility, EDS, dental care, splint use, and prior injections.
During treatment, prolotherapy solution is injected into selected TMJ-related targets when clinically appropriate.
Patients may feel pressure, soreness, or temporary pain flare after the procedure. Recovery instructions may include avoiding excessive chewing, modifying activity, following jaw-care guidance, and coordinating with dental or physical therapy care when needed. Relief, if it occurs, may be gradual and is not guaranteed. If symptoms persist, MPM may reassess whether the primary driver is joint instability, muscle overactivity, disc mechanics, dental disease, headache overlap, nerve pain, or cervical dysfunction.
I cannot say enough good things about Manhattan Pain Medicine. From the moment I walked in, I felt truly cared for and taken seriously. Dr. Nino Mikaberidze, Director of Rheumatology, is exceptional — knowledgeable, compassionate, and incredibly thorough. She takes the time to listen, explains every...
The best care I've received as a chronic pain patient. I traveled from out of state to visit Manhattan Pain Medicine because I could not find knowledgeable doctors in my hometown for my hypermobility, and Ehlers-Danlos syndrome symptoms and comorbidities. Let me tell you, it was worth every travel e...
I was injured in a bicycle accident over 8 years ago. I’ve suffered throughout the years since my accident with nothing seeming to work. PT, Yoga, lifestyle changes, NOTHNG! I finally made an appointment with Dr Kane and I’m feeling an improvement in my life. I no longer stay up all night in pain, a...
One of the best experiences, if not the best, I have ever had at the doctor’s office. From the front desk to the nurses to the PA assisting the doctor this was a great experience. Dr.Nino actually listened to me and came up with a game plan. Would recommend this practice to as many people as I could...
I have very unique & severe nerve pain from CRPS which has no known specific cure. Dr. Siefferman has a huge tool box, far greater than the other 23 Drs. I have seen. He saved me from jumping off a bridge and continues to help me with both treatments and advice. Dr. S. is in a different league!
After two years of searching and feeling lost and let down, I finally found real help at Manhattan Pain Medicine. With Dr. Siefferman, Adam Rosenberg, Dr. Mikaberidze, and the whole team, I feel heard, supported and understood. Every symptom is being considered and I’m finally getting answers with m...
Why is Dr Dr. Tayyaba Ahmed one of the top pevic Floor specialists - 1- She wants to know a full history of what led the patient to get to this point. 2 - She listens intensley to the patient 3- She does not rush you 4- Extremely skilled at giving pelvic floor injections 5- I thank my luck stars she...
The staff was friendly and helpful. Dr. Siefferman was thoughtful, listened, asked questions and proposed simple safe ways to come to further conclusions regarding my pain and discomfort. The office staff including Dr. Siefferman is responsive even after the initial in-person visit. Very pleased.
Dr. Siefferman is a brilliant provider. While my pain is still a work in progress, Dr Siefferman always gives me options and explains his reasoning behind things. He listens to my feedback and concerns. I never feel rushed; and am grateful he works to meet me where I am. I highly recommend him.
What a great find! They listen to me, I listen to them and the diagnosis is made and a plan developed to develop an approach to treat all of my chronic pain. I wish I could have discovered this type of treatment sooner. This doctor and group give me hope.
TMJ prolotherapy is a regenerative injection approach that may be considered for selected patients with temporomandibular joint pain, jaw instability, clicking, locking, or hypermobility-related TMJ symptoms. It typically involves injecting a solution into selected TMJ-related targets to stimulate a local tissue response. TMJ prolotherapy is not a cure-all and is not appropriate for every TMJ condition. MPM evaluates the jaw joint, muscles, bite mechanics, cervical spine, headache overlap, and hypermobility before considering treatment.
Prolotherapy is intended to create a controlled local tissue response in a targeted area. For TMJ dysfunction, it may be considered when symptoms appear related to ligamentous support, joint laxity, instability, or mechanical irritation. It does not guarantee ligament tightening, disc repositioning, cartilage regrowth, or permanent repair. TMJ pain may also come from muscle overactivity, dental issues, inflammatory arthritis, nerve pain, headache disorders, or cervical spine dysfunction. MPM evaluates these possibilities before recommending prolotherapy.
TMJ prolotherapy may be considered for selected patients whose symptoms appear related to jaw joint instability, laxity, or recurrent mechanical irritation. This may be relevant for some patients with hypermobility, EDS, jaw slipping, clicking, or a sense that the jaw feels loose or unstable. It does not guarantee stabilization and should not replace strengthening, jaw mechanics work, dental care, or specialist evaluation when those are needed. MPM determines whether instability appears to be a meaningful driver before recommending treatment.
TMJ prolotherapy may be considered in selected cases of jaw clicking or locking when the symptoms appear related to joint laxity or mechanical irritation. However, clicking and locking can also involve disc displacement, arthritis, muscle spasm, joint inflammation, dental factors, or other TMJ disorders. Sudden severe locking, inability to open or close the mouth, trauma, fever, swelling, or rapidly worsening symptoms should be evaluated promptly. MPM evaluates the cause before considering prolotherapy.
TMJ prolotherapy may be considered for selected patients with hypermobility or EDS-related jaw pain when a specific TMJ instability or ligament-related pattern is identified. It does not cure EDS, hypermobility spectrum disorder, cervical instability, or complex chronic pain. Patients with hypermobility often need a broader plan that may include jaw mechanics, cervical stabilization, physical therapy, dental or orofacial care, pacing, and evaluation for headache or nerve pain overlap. MPM evaluates candidacy carefully.
TMJ prolotherapy and Botox target different problems. Prolotherapy may be considered when symptoms appear related to joint laxity, ligamentous support, or instability. Botox for TMJ dysfunction is typically considered when jaw muscle overactivity, clenching, bruxism, or masticatory muscle pain is a major contributor. Neither treatment is right for every patient. MPM evaluates whether symptoms are joint-driven, muscle-driven, nerve-related, dental, cervical, inflammatory, or headache-related before recommending a treatment pathway.
TMJ prolotherapy and PRP are different regenerative approaches. Prolotherapy typically uses an injected solution, often dextrose-based, to stimulate a local tissue response. PRP is made from the patient’s own blood and processed to concentrate platelets before injection. Each option has different preparation steps, evidence limits, cost considerations, and recovery expectations. MPM determines whether prolotherapy, PRP, Botox, conservative care, dental care, or another treatment better fits the diagnosis.
No. TMJ prolotherapy is not the same as stem cell therapy. Prolotherapy usually involves injecting a solution into selected musculoskeletal targets. Stem cell, exosome, amniotic, cord-derived, Wharton’s jelly, or similar regenerative products are different and are often marketed with broad claims. Many of these products are not FDA-approved for orthopedic or chronic pain conditions. MPM avoids unsupported regenerative claims and focuses on realistic expectations, diagnosis, and patient selection.
The number of TMJ prolotherapy sessions depends on the diagnosis, target, response, safety, and recovery plan. Some patients may not need repeated treatment, while others may be considered for additional sessions only if early response and clinical reasoning support it. Prolotherapy should not be repeated automatically. MPM reassesses jaw pain, clicking, locking, function, side effects, and whether other treatments or specialist coordination are needed.
Patients may feel pressure, soreness, or a temporary pain flare during or after TMJ prolotherapy. The degree of discomfort varies by patient, target, technique, and pain sensitivity. Some patients with hypermobility, chronic pain, medical trauma, or central sensitization may need additional preparation and expectation-setting. MPM reviews the procedure, comfort measures, recovery plan, and risks before treatment. Significant worsening, fever, facial swelling, or inability to open or close the mouth should be evaluated promptly.
Risks may include post-procedure soreness, pain flare, bruising, bleeding, infection, allergic reaction, temporary worsening, incomplete relief, facial discomfort, jaw stiffness, nerve irritation, or vascular injury. TMJ symptoms may persist if the main driver is muscle overactivity, disc displacement, dental disease, inflammatory arthritis, nerve pain, cervical dysfunction, or headache overlap. Urgent evaluation is needed for fever, facial swelling, suspected dental infection, severe jaw locking, trouble swallowing, trouble breathing, new neurological symptoms, or rapidly worsening symptoms.
TMJ prolotherapy is an injection-based procedure, but it should not be described as an FDA-approved cure for TMJ dysfunction, jaw instability, hypermobility, EDS, arthritis, or chronic pain. Regulatory status depends on the product, preparation, and use. MPM discusses evidence limits, risks, alternatives, and expectations before treatment. Patients should be cautious about broad regenerative claims, especially involving stem cell, exosome, amniotic, or cord-derived products marketed for pain.
TMJ prolotherapy may not be appropriate when symptoms are primarily caused by dental infection, inflammatory arthritis, disc displacement requiring different care, severe jaw locking, fracture, tumor, nerve pain, headache disorder, or muscle overactivity without a clear joint instability component. It may also be delayed when symptoms are acute, rapidly worsening, or medically unstable. MPM may recommend dental care, oral surgery, orofacial pain care, neurology, headache evaluation, physical therapy, Botox, PRP, or conservative treatment instead.
MPM considers the patient’s jaw symptoms, joint mechanics, hypermobility history, EDS-related features, neck pain, headache overlap, bite and dental history, prior splints, prior injections, physical therapy response, imaging when available, and red flags. The team evaluates whether the symptoms appear related to TMJ joint laxity or instability and whether prolotherapy fits the broader care plan. If another pain generator is more likely, MPM may recommend a different treatment or specialist evaluation.
Before care begins, our team helps patients understand the practical side of treatment, including insurance verification, out-of-network benefits, cost-share estimates, self-pay options, and billing questions. We believe patients should have as much clarity as possible before moving forward.
TMJ prolotherapy is a regenerative injection approach that may be considered for selected patients with temporomandibular joint pain, jaw instability, clicking, locking, or hypermobility-related TMJ symptoms. It is often discussed when patients feel the jaw is loose, slipping, unstable, or mechanically irritated despite conservative care.
At Manhattan Pain Medicine (MPM), TMJ prolotherapy NYC care begins with diagnosis-first evaluation. The goal is to determine whether symptoms appear related to TMJ joint laxity, ligamentous support, instability, or chronic mechanical irritation. TMJ prolotherapy is not a universal TMJ treatment and is not a cure for jaw pain.
TMJ pain can come from many sources. Some patients have joint laxity or instability. Others have disc displacement, arthritis, muscle overactivity, bruxism, dental issues, trigeminal neuralgia, headache disorders, cervical spine dysfunction, inflammatory arthritis, or central pain mechanisms. These conditions can feel similar but require different treatment plans.
A patient with jaw muscle overactivity may benefit more from Botox, physical therapy, oral appliance care, or muscle-focused treatment. A patient with dental disease may need dental or oral surgery care. A patient with headache overlap may need headache-focused evaluation. A patient with hypermobility or EDS may need a broader plan that considers cervical mechanics, joint instability, and tissue tolerance.
Patients with EDS or hypermobility spectrum disorder may experience TMJ symptoms because of ligamentous laxity, joint instability, muscle compensation, or altered mechanics. Some may also have neck pain, headache, suspected craniocervical instability, or broader joint instability. TMJ prolotherapy may be considered only when the jaw joint itself appears to be an appropriate target.
TMJ prolotherapy does not cure EDS, hypermobility, CCI, Chiari malformation, CSF outflow obstruction, intracranial hypertension, jugular stenosis, tethered cord, headache disorders, or chronic pain. It may be one part of a coordinated plan that includes jaw mechanics, cervical stabilization, dental care, physical therapy, pacing, pain psychology, or specialist coordination.
TMJ prolotherapy, Botox, PRP, and conservative TMJ care have different roles. Prolotherapy may be considered when joint laxity or instability appears to be a meaningful contributor. Botox is typically considered when masticatory muscle overactivity, clenching, bruxism, or jaw muscle pain is a major driver. PRP may be considered for selected joint or soft tissue targets, depending on the diagnosis. Conservative care often includes soft diet, jaw exercises, splints, physical therapy, medication, and behavioral strategies.
No single treatment is appropriate for every TMJ patient. MPM evaluates whether the primary issue is joint-driven, muscle-driven, dental, neurologic, inflammatory, cervical, headache-related, or mixed before recommending a pathway.
Before treatment, MPM reviews the patient’s symptoms, jaw mechanics, hypermobility history, cervical symptoms, headache overlap, dental history, prior splints, prior injections, imaging, and red flags. If TMJ prolotherapy is appropriate, the procedure involves injecting a prolotherapy solution into selected TMJ-related targets.
Patients may experience soreness, pressure, stiffness, or a temporary pain flare. Recovery may involve modifying chewing, avoiding excessive jaw loading, coordinating with dental or physical therapy care, and monitoring symptoms. Relief, if it occurs, may be gradual and is not guaranteed.
Evidence for TMJ prolotherapy varies by patient group, protocol, and diagnosis. Some studies suggest possible improvement in selected TMJ dysfunction or hypermobility populations, but evidence quality and patient selection vary. MPM avoids unsupported claims about ligament tightening, disc repositioning, cartilage regrowth, joint reconstruction, nerve regeneration, or permanent healing.
Urgent evaluation is needed for fever, facial swelling, suspected dental infection, sudden severe jaw locking, inability to open or close the mouth, trauma, new facial weakness, new neurological symptoms, severe sudden headache, vision changes, trouble swallowing, trouble breathing, chest pain, or rapidly worsening symptoms.
For selected patients, TMJ prolotherapy may be one tool within a broader jaw, cervical, and hypermobility-aware care plan. MPM’s role is to determine whether the diagnosis, mechanics, safety profile, and treatment goals support its use within a coordinated, medically responsible framework.
